December 1st, 2020
New tool broadens ability to program stem cells, study SARS-CoV-2
TFome technology, advanced through Blavatnik Biomedical Accelerator, may contribute to new cell therapies
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Blavatnik
July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
June 17th, 2020
OTD welcomes 2020-2021 Blavatnik Fellows in Life Science Entrepreneurship
Five Fellows will work with innovators across Harvard community, advance commercialization of life-science technologies
April 9th, 2020
Injections to become pills, in vision of Harvard-launched startup
New formulations enable oral delivery of therapeutics traditionally delivered intravenously
December 6th, 2019
Empowering mucosal healing with an engineered probiotic
Genetically programmed, living hydrogel material facilitates intestinal wound healing and may lead to a therapy for patients with inflammatory bowel disease
